Tag Archives: settlement

GlaxoSmithKline settles case with woman who linked her use of antidepressant Paxil to the death of her infant son

A settlement has been reached in a lawsuit filed against a pharmaceutical company by a Watertown woman who linked her prescribed use of Paxil to the death of her infant son, according to court files. Jennifer Berg of Watertown sued SmithKline Beecham, doing business as GlaxoSmithKline, in October 2007. The complaint said Nathan Berg died in 2004 because of a heart disorder caused by her use of the antidepressant Paxil while she was pregnant.

Heavy Doses—Drug Company J&J Pays Docs Millions for “speaking & consulting gigs”

Speaking and consulting gigs for drug companies can be lucrative for doctors. Birmingham, Alabama, psychiatrist James E. Parker was paid more than $21,000 in speaking fees between January and March by a Johnson & Johnson company that sells mental health drugs.

Eli Lilly to pay $24 million in Utah Attorney General’s Zyprexa lawsuit/AG says “we want their bad conduct to stop”

Utah Attorney General Mark Shurtleff sued the company after a nearly four-year investigation revealed that Lilly concealed its knowledge of significant weight gain and obesity associated with the anti-psychotic medication Zyprexa. Investigators also showed that Lilly’s sales representatives illegally promoted the drug for uses not approved by the U.S. Food and Drug Administration.

$112 million settlement: charged with kickbacks from drug company & recommending docs prescribe antipsychotic drug Risperdal

The U.S. Justice Department said that Johnson & Johnson’s kickbacks to Omnicare, the largest U.S. provider of pharmacy services to nursing homes, took multiple forms, including rebates that were conditioned on Omnicare engaging in an ‘Active Intervention Program’ for Risperdal and payments disguised as data purchase fees, educational grants, and fees to attend Omnicare meetings.

Eli Lilly’ s confidential settlement with seven states over its antipsychotic drug Zyprexa

Eli Lilly & Co. agreed to settle, on confidential terms, lawsuits filed by seven states alleging the company improperly marketed its antipsychotic drug Zyprexa. The state lawsuits were seeking reimbursement for funds spent on Medicaid, the government health program for the poor. Zyprexa, part of a class of medications called atypical antipsychotics, has been linked to excessive weight gain and diabetes. The lawsuits also claim Lilly failed to properly warn of Zyprexa’s side effects.